ng-nitroarginine methyl ester has been researched along with Deep Vein Thrombosis in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amic, E; Amic, F; Bilic, Z; Boban Blagaic, A; Drmic, D; Horvat Pavlov, K; Klicek, R; Kokot, A; Krezic, I; Milkovic Perisa, M; Pajtak, A; Peklic, M; Rakic, M; Seiwerth, S; Sikiric, P; Tvrdeic, A; Vidovic, T; Zizek, H; Zovak, M | 1 |
Chen, W; Dong, R; Feng, W; Hu, D; Tu, L; Wang, DW; Xia, C; Xu, X; Yang, Y; Zhang, Y | 1 |
Buczko, W; Chabielska, E; Kucharewicz, I; Matys, T; Pawlak, R; Rółkowski, R | 1 |
3 other study(ies) available for ng-nitroarginine methyl ester and Deep Vein Thrombosis
Article | Year |
---|---|
Bypassing major venous occlusion and duodenal lesions in rats, and therapy with the stable gastric pentadecapeptide BPC 157, L-NAME and L-arginine.
Topics: Animals; Arginine; Colitis, Ischemic; Collateral Circulation; Disease Models, Animal; Duodenum; Humans; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxidative Stress; Peptide Fragments; Protective Agents; Proteins; Random Allocation; Rats; Rats, Wistar; Treatment Outcome; Veins; Venous Thrombosis | 2018 |
Exogenous Bradykinin Inhibits Tissue Factor Induction and Deep Vein Thrombosis via Activating the eNOS/Phosphoinositide 3-Kinase/Akt Signaling Pathway.
Topics: Animals; Bradykinin; Chromones; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Human Umbilical Vein Endothelial Cells; Humans; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Monocytes; Morpholines; NF-kappa B; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Receptor, Bradykinin B2; RNA, Messenger; Signal Transduction; Thromboplastin; Venous Thrombosis | 2015 |
Thiol repletion prevents venous thrombosis in rats by nitric oxide/prostacyclin-dependent mechanism: relation to the antithrombotic action of captopril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Bleeding Time; Blood Coagulation; Blood Pressure; Captopril; Cyclooxygenase Inhibitors; Enzyme Inhibitors; Epoprostenol; Fibrinolysis; Fibrinolytic Agents; Hemostasis; Indomethacin; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Prothrombin Time; Rats; Rats, Wistar; Sulfhydryl Compounds; Venous Thrombosis | 2000 |